Nymox Pharma (NYMX) Takes Upward Bounce; Jefferies Eyeing Potential In Energy Recovery (ERII)
Nymox Pharmaceutical Corp. (Nasdaq:NYMX) stock soared to touch the $4.08 mark during Tuesday’s market activity, currently changing hands at $3.78, up $1.00 (or +35.97%) with 9.01M shares traded so far, representing a large increase in activity versus its average volume (3m) of 1.22M
There appears to be no particular recent news from the biopharmaceutical company in the street that may explain the stock’s rally
Nymox Pharmaceutical, which engages in the research and development of drugs for the aging population, has 46.14M Shares Outstanding and NYMX stock 52-week range is from $1.62 to $5.79 per share
Shares of Energy Recovery, Inc. (Nasdaq:ERII) surged more than 11.5% to nearly one-year high levels in early trade Tuesday after brokerage firm Jefferies upgraded the company’s stock from a Hold to a Buy rating, also raising its price target to $20.00 from $8.00.
ERII stock is trading at $13.13, up $0.44 (or +3.47%) and 1.42M of its shares changed hands so far
Energy Recovery, which provides energy solutions to industrial fluid flow markets worldwide, has 52.05M Shares Outstanding and ERII stock 52-week range is between $2.07 and $14.29 per share
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/